Hans Lederhuber

Time flies and @bjsurgery.bsky.social / @bjsopen.bsky.social editorial assistants rotate. Huge gratitude goes to our out-going editorial assistants Yung Lee, @hansl16.bsky.social and Laura Maggino - I’ve learned a great deal from you! 🙏 Terms end, but you will be part of BJS Family forever!

Absolut machen die Sorgen. Nur die Lösung ist ja nicht zu sagen, man hätte mal die AFD verbieten sollen - hat man ja bei der NPD gesehen, dass das kaum möglich ist.

Wobei der Ausgangspost halt auch nur polemischer Blödsinn ist. Als ob man die AFD einfach mal verbieten könnte. Wobei das Narrativ ja Wasser auf deren Mühlen vom Unrechtsstaat ist.

X's current value is approx. 44 billion USD. They will never pay anything though - has any company ever?

📣Please share your thoughts and help shaping tomorrow‘s review process. 📣

📅 The survey below is still open until tomorrow, 23/3/25 at 23:59 CET

@facs.org @gio-marchegiani.bsky.social @jbmatthews.bsky.social @drneil.bsky.social @halletjulie.bsky.social

Editor assistant bursaries 2025 The BJS Foundation editor assistant bursaries aim to encourage young surgeons to take an interest in medical publishing. Recruited annually, editor assistant bursaries are suitable for applicants at…

📢 Editor Assistant Bursary Award 2025!

Join @BJSurgery.bsky.app & @BjsOpen.bsky.app editorial teams.

📅 Closing date is 30th April 2025

💫 We would appreciate sharing of this post - thank you!

#SurgSky #MedSky

More info here:

#SAGES2025 welcomes all children and adults who act like children.

And I think this is what recent numbers show. X as a platform is not doing well, they lose money and customers. But other SoMe do not gain proportionally (maybe LinkedIn that sees increasing numbers of costumers who use it not only to self-promote).

I‘m already double-posting parts here and on X. But not enough people following on Bluesky.
Another part is that people who cancelled their account or have dead accounts on X do not open a new account on other SoMe. As for me personally, I’m less and less interested in SoMe as a concept.

I have. Unfortunately, Bluesky hasn’t gained enough traction so far 😢

@wannabehawkeye.bsky.social @neilflochmd.bsky.social @ewenharrison.bsky.social @marcbesselink.bsky.social

Understanding Peer Review Challenges Among Surgeons: A BJS Initiative Take this survey powered by surveymonkey.com. Create your own surveys for free.

📢 Calling All Surgical Reviewers & Authors!
Your insights matter! Help us improve the peer review process by taking our short survey.
Together, we can shape the future of surgical research.

👉 Take the survey here: www.surveymonkey.com/r/YLY69HZ

@drjuliomayol.bsky.social @bjsacademy.bsky.social

@liangrhea.bsky.social @carlybisset.bsky.social @scullingmonkey.bsky.social @facs.org @jbmatthews.bsky.social @robjimfleming.bsky.social @tsengjennifer.bsky.social @beckybeckyfish.bsky.social @rebgross.bsky.social @debbykeller.bsky.social @orthopodreg.bsky.social @laurakoskenvuo.bsky.social

Ich mag das Program der Linken nicht. Aber ich mag Reichenek und auch Gysi. Die einzigen, die mich emotional ansprechen.

Tief enttäuscht von den Grünen war ich.
Und ich hoffe wirklich, dass die FDP rausfliegt.

Schlechte Politik hat die Menschen an die Ränder getrieben. Aber auch die Linke, mit einer tollen Heidi Reichenek, bei 9%.
Spannend.

That would be really nice indeed.
But then it would no longer be a headline, as it is the case with all the other visiting professors who never make it onto the news.
But it’s still a bit like with the old gravestones on German graveyards where it says „hier ruht Frau Chefarzt-Gattin xy“.

It is morally repugnant that the world's richest man is working to de-fund programs that give aid to some of the neediest people on Earth.
Elon Musk's legacy will be that of a weak narcissist who, even with untold riches and power, was unhappy, unloved, unfulfilled, and unredeemable.

YouTube video by Surgeons' Lives - Stuff that Matters Neil Smart - Surgeon and Unexpected Patient

Such a great, funny, heart-breaking interview between John Monson & Neil Smart.
For everybody who hasn’t watched it yet, this is a must-see.

#surgsky @bjsurgery.bsky.social @drjuliomayol.bsky.social @sages.org @liangrhea.bsky.social @villesallinen.bsky.social

www.youtube.com/watch?v=MyXJ...

Amen 🙏 @thelancet.bsky.social

Is there a “good” stress 😣 in surgery?!

🇫🇷 800 procedures / 40 surgeons @jama.com surgery

🧠 Sympathovagal balance of the surgeon in the first 5 minutes measured

🪡 Increased stress associated to less major complications 🤷

Feeling stressed 😰 already?!

jamanetwork.com/journals/jam...

Wide angle sunrise with orange colored clouds reflected on a glassy beach.

Ata mārie BlueSky. This is sunrise for Friday, 17 January, from Makorori Beach, Aotearoa/New Zealand.

#PCC25 registration open for the robotic colorectal event of the year!

🔪 Open 🔦 Laparoscopic 🤖 Robot Pancreatoduodenectomy Randomised Controlled Trials

🧮 Network Meta-Analysis on 7 RCT 1.3 K patients

🔦 LPD ⬇️ LOS and blood loss vs. OPD
🔪 OPD ⬇️ OR time vs. LPD

🤖 RPD similar OPD but data preliminary..

🫵 Surprised? #HPBSky #SurgSky

journals.lww.com/aosopen/full...

1040 on a Sunday and I’ve cleaned up one half of the mess from son‘s birthday party yesterday and the other half still waiting…

Now for a quick nap

#worklifebalance #dadjobs

50mm is the best :)

✨The end of 2⃣0⃣2⃣4⃣ nears; over the next days, 🔝10 papers that have changed my practice & shaped research

Start with anatomy review of SMA 👉https://tinyurl.com/mr3kdkxz

Branch 1 & 2 perfuse mean 195cm small intestine
➡️Many proximal #NETs mesenteric masses can be resected

#SurgSky #NETSky #HPBSky

2⃣0⃣2⃣4⃣ Wrapped Pancreas! 🎄

1⃣ January The NORPACT-1 trial released on @thelancet.bsky.social Gastroenterology and Hepatology

Neoadjuvant FOLFIRINOX 🤜🤛 Upfront surgery for resectable pancreatic cancer

🫵 What is your practice now !? 🫵

www.thelancet.com/journals/lan...

#HPBSky #PancreasSky

Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial In patients undergoing liver resection, hypovolaemic phlebotomy reduced perioperative red blood cell transfusion and improved operative conditions, with no statistically significant increase in the incidence of complications compared with usual care. Hypovolaemic phlebotomy should be considered for routine use in patients undergoing liver resection at higher risk of bleeding.

PRICE-2 trial out @LancetGastroHep :
Hypovolemic phlebotomy (7-10 mL/kg) versus usual care for liver resection w high risk of blood loss.

Primary outcome: blood transfusion
—> Phlebotomy 8%
—> Usual care 16%

Severe complication rate similar (17% vs 16%)

www.thelancet.com/journals/lan...

SJS is doing great!

Awesome 🤩